Last reviewed · How we verify

NCT05837910

Radicle Calm 2: A Study of Health and Wellness Products on Feelings of Anxiety, Stress, and Health Outcomes

Completed NA Last updated 20 May 2024
What this trial tests

NA trial testing Calm Active Study Product 1.1 Usage in Anxiety in 3,853 participants. Completed in 26 April 2024.

Timeline
3 April 2023
Primary endpoint
30 November 2023
26 April 2024

Quick facts

Lead sponsorRadicle Science
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment3,853
Start date3 April 2023
Primary completion30 November 2023
Estimated completion26 April 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Radicle Science — full company profile →

Who can join

Adults 21 to 105, any sex, with Anxiety or Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized, double-blinded, placebo-controlled study assessing the impact of health and wellness products on feeling of anxiety, stress, and other health outcomes

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Calm Active Study Product 1.1 Usage

Trials testing the same drug.

Other recruiting trials for Anxiety

Currently open trials in the same condition.

Other Radicle Science trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05837910.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing